cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test
K-Number: K243406 · 2025-04-25
Device Summary
Frequently Asked Questions
What is the cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test?
cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test is a medical device that received FDA 510(k) clearance on 2025-04-25. It is manufactured by Roche Molecular Systems, Inc.. The 510(k) number is K243406.
When was cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test approved by the FDA?
cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test received FDA 510(k) clearance on 2025-04-25, under approval number K243406.
What company makes cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test?
cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test is manufactured by Roche Molecular Systems, Inc..
What is the FDA product code for cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test?
The FDA product code for cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test is QOF.
Other Devices by Roche Molecular Systems, Inc.
Related Devices (Code: QOF)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.